Pseudotumor cerebri surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
* Visual acuity loss which is the result of papilledema | * Visual acuity loss which is the result of papilledema | ||
* Resistant headache | * Resistant headache | ||
* hypotesion | * hypotesion<ref name="pmid2679506">{{cite journal |vauthors=Corbett JJ, Thompson HS |title=The rational management of idiopathic intracranial hypertension |journal=Arch. Neurol. |volume=46 |issue=10 |pages=1049–51 |date=October 1989 |pmid=2679506 |doi= |url=}}</ref> | ||
==Surgery== | ==Surgery== | ||
Revision as of 14:58, 30 July 2018
|
Pseudotumor cerebri Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pseudotumor cerebri surgery On the Web |
|
American Roentgen Ray Society Images of Pseudotumor cerebri surgery |
|
Risk calculators and risk factors for Pseudotumor cerebri surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Indications
Surgery is not the first-line treatment option for patients with pseudotumor cerebri. Surgery is usually reserved for patients with either:
- Progress of visual field loss despite medical treatment with maximum dosage
- Visual acuity loss which is the result of papilledema
- Resistant headache
- hypotesion[1]